Verification evidence is still being completed.
QIAGEN
Hilden, Germany
- Verified lead
- Thierry Bernard
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer and Managing Director
- 2026 technical specialization
- Molecular Diagnostics and Sample-to-Insight Systems
- Review cycle
- May 2026
- Full address
- QIAGEN Strasse 1, 40724 Hilden, Germany
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official QIAGEN executive committee page confirming Thierry Bernard as CEO and Managing Director.
- Editorial note
- Diagnostics and molecular-workflow platform operating under ISO 9001/13485 controls with sample-prep, PCR, and bioinformatics manufacturing depth.
Molecular Diagnostics and Sample-to-Insight Systems
ISO 9001:2015, ISO 13485:2016, MDSAP
Diagnostics and molecular-workflow platform operating under ISO 9001/13485 controls with sample-prep, PCR, and bioinformatics manufacturing depth.

QIAGEN
Molecular Diagnostics and Sample-to-Insight Systems · Global diagnostics manufacturing
Diagnostics and molecular-workflow platform operating under ISO 9001/13485 controls with sample-prep, PCR, and bioinformatics manufacturing depth.
- Lead
- Thierry Bernard (verified ↗)
- Address
- QIAGEN Strasse 1, 40724 Hilden, Germany (source ↗)
- Compliance
- ISO 9001:2015 · ISO 13485:2016
- Last reviewed
- 14 Mar 2026 (3mo ago)
- Scale
- Global diagnostics manufacturing
- Capabilities
- Sample Preparation · PCR and NGS Workflow Systems · Molecular Diagnostics Assays
- Founded
- 1984
- Headcount
- 5001-10000
- Company page (open ↗)

Thierry Bernard
Chief Executive Officer and Managing Director
Official QIAGEN global presence page listing QIAGEN Strasse 1 in Hilden.
Open sourceGlobal diagnostics manufacturing
Hilden, Germany. Molecular Diagnostics and Sample-to-Insight Systems. Review completed on 14 Mar 2026.
European and international in vitro diagnostics oversight
ISO 9001:2015, ISO 13485:2016, MDSAP
QIAGEN certified quality management system: Valid until 14 Jun 2027
QIAGEN quality management system and DQS certificate summary.Molecular Diagnostics and Sample-to-Insight Systems
Diagnostics and molecular-workflow platform operating under ISO 9001/13485 controls with sample-prep, PCR, and bioinformatics manufacturing depth.
QIAGEN joins the verified German equipment core through the current executive committee page naming Thierry Bernard as CEO and Managing Director.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- VERIFIED ACTIVE 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Frequently asked questions
- Where is QIAGEN located?
- QIAGEN operates from QIAGEN Strasse 1, 40724 Hilden, Germany, Hilden, Germany.
- Who runs QIAGEN?
- QIAGEN is led by Thierry Bernard, Chief Executive Officer and Managing Director. Verified 14 Mar 2026.
- What certifications does QIAGEN hold?
- QIAGEN is documented under ISO 9001:2015, ISO 13485:2016.
- What does QIAGEN do?
- Diagnostics and molecular-workflow platform operating under ISO 9001/13485 controls with sample-prep, PCR, and bioinformatics manufacturing depth. Core capabilities: Sample Preparation, PCR and NGS Workflow Systems, Molecular Diagnostics Assays.
Related technical briefs
Briefs that name Hilden as a covered market or city.
